Understanding Philips Stock Symbol and Performance

Philips stock symbol is listed as PHG on the Euronext Amsterdam stock exchange and as PHG.N on the OTC Pink market in the United States.

The stock symbol PHG represents the company's Dutch name, Koninklijke Philips N.V., which translates to Royal Philips NV.

The company has a long history, dating back to 1891 when it was founded by Gerard Philips and his father Frederik in the Netherlands.

As of 2022, Philips has a market capitalization of around $40 billion, making it one of the largest companies in the Netherlands.

Philips is a Dutch multinational conglomerate founded in 1891 by Gerard Philips and his father Frederik Philips.

The company is headquartered in Amsterdam, Netherlands.

Philips is a leading player in the healthcare, consumer lifestyle, and lighting industries.

They are known for their innovative products, such as the first electric lamp in 1891 and the first compact disc player in 1982.

The company has a strong presence in over 100 countries worldwide.

Philips has a rich history of innovation and has been at the forefront of several technological advancements.

Koninklijke Philips's revenue in 2024 was 18.02 billion, a decrease of -0.81% compared to the previous year.

The company's losses in 2024 were -702.00 million, which is 50.6% more than in 2023.

Philips stock valuation has seen significant fluctuations, with a capitalization range of 19.12B to 34.39B.

The P/E ratio for 2025 is estimated at 29.7x, while for 2026 it's expected to be around 20x.

Here's a summary of the estimated P/E ratios:

The enterprise value of Philips has also changed over time, ranging from 23.64B to 42.51B.

Shares of Royal Philips rose on Monday, and the reason is quite interesting. The company's first-quarter earnings calmed some investors' concerns.

The company's earnings report was a welcome relief for investors, who had been worried about the impact of the recall on the company's financials.

Royal Philips has been dealing with a recall of sleep apnea and respiratory products, which had some investors on edge.

The recall, however, didn't seem to have had a significant impact on the company's earnings, which is good news for investors.

Here's a quick rundown of the company's recent earnings:

The company's earnings report was a positive surprise, and it's no wonder that investors were relieved to see the company's financials in good shape.

The recent earnings report and upgrades from analysts have helped to boost investor confidence in the company.

Valuation is a crucial aspect of understanding a company's financial health. Philips NV's market capitalization fluctuated between 19.12B and 34.39B.

The price-to-earnings (P/E) ratio is a key metric for investors. In 2025, Philips NV's P/E ratio is expected to be around 29.7x.

Enterprise value, which includes debt, is another important metric. Philips NV's enterprise value ranged from 23.64B to 42.51B.

A high free-float percentage indicates that a significant portion of the company's shares are available for trading. Philips NV's free-float percentage is 81.81%.

Yield, or dividend yield, is a measure of a company's dividend payment relative to its stock price. Philips NV's yield for 2025 and 2026 is expected to be 3.57% and 3.71% respectively.

Here are the key valuation metrics for Philips NV:

The enterprise value of Philips NV also varied significantly, ranging from 23.64B to 46.97B.

Analysts' recommendations for Philips NV are overwhelmingly positive, with multiple firms issuing Buy ratings.

Goldman Sachs and UBS have both given Philips NV a Buy rating, with UBS even upgrading their recommendation and raising their price target.

DZ Bank and Deutsche Bank have taken a more neutral stance, giving Philips NV a Neutral rating.

Here's a summary of the analysts' recommendations:

UBS's upgrade to Buy and price target increase is a significant development, and it's worth keeping an eye on the company's future performance.